Related Experiment Video
Updated: Mar 19, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.8K
Generic medications for hepatitis C
Donald M Jensen1, Phoebe Sebhatu1, Nancy S Reau1
1Section of Hepatology, Department of Medicine, RUSH Medical Center, Chicago, IL, USA.
Summary
High-cost hepatitis C medications face access limits. Generic versions offer affordable alternatives, but personal importation raises medical and legal questions.
Area of Science:
- Hepatology
- Pharmacoeconomics
- Pharmaceutical Law
Background:
- Hepatitis C treatment advancements include highly effective oral agents.
- High costs of these novel drugs create access barriers in resource-limited healthcare systems.
- Generic licensure agreements enable lower-cost formulations in some regions.
Purpose of the Study:
- To review the medical and legal considerations of personal drug importation for hepatitis C treatments.
- To address the challenges posed by medication access limitations for hepatitis C antivirals.
- To explore the viability of importing generic hepatitis C drugs.
Main Methods:
- Literature review of medical and legal aspects of drug importation.
- Analysis of regulatory requirements for generic drug quality and bioequivalence.
- Discussion of ethical considerations in patient access to medication.
Main Results:
- Generic hepatitis C drugs are significantly cheaper than originator products.
- Personal drug importation is driven by unmet medical needs and cost barriers.
- Manufacturing and distribution regulations are crucial for ensuring generic drug safety and efficacy.
Conclusions:
- Personal importation of generic hepatitis C medications presents complex medical and legal issues.
- Ensuring the quality and bioequivalence of imported generics is paramount.
- Balancing drug accessibility with regulatory oversight is essential for public health.
Related Concept Videos
01:25Hepatitis
6
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
6
01:30Inhibitors of Viral Protein Synthesis
1
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
1
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
327
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
327
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
324
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
324
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
236
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
236